TSS
CMPX icon

Two Sigma Securities’s Compass Therapeutics CMPX Stock Holding History

Two Sigma Securities’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.5K Buy
+29,451
New +$86.9K 0.01% 1359
2025
Q1 		– Sell
-13,887
Closed -$20.1K – 1562
2024
Q4 		$20.1K Buy
+13,887
New +$23.1K ﹤0.01% 1319

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Two Sigma Securities's CMPX Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Compass Therapeutics (CMPX) in Q2 2026: 29,451 shares worth $64.5K. The stake represents 0.01% of the portfolio and ranks #1359 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in CMPX as recently as Q4 2024.

Two Sigma Securities first reported a position in CMPX in Q4 2024 and has held it in 2 quarters since. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Two Sigma Securities held 29,451 shares of Compass Therapeutics worth $64.5K as of Q2 2026.
  • Compass Therapeutics was a new Two Sigma Securities position in Q2 2026.
  • Compass Therapeutics made up 0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1359 holding.
  • Two Sigma Securities first reported a position in Compass Therapeutics in Q4 2024 and has held it in 2 quarters since.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.